missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Complement C3 Antibody (4D12), Novus Biologicals™
Rabbit Monoclonal Antibody
Marca: Novus Biologicals NBP3-26471-100ul
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Complement C3 Monoclonal antibody specifically detects Complement C3 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry
Especificaciones
Complement C3 | |
Monoclonal | |
Unconjugated | |
PBS, pH 7.4, 150mM NaCl and 50% glycerol | |
Rabbit | |
Affinity purified | |
RUO | |
Primary | |
Human | |
Purified |
Western Blot, Flow Cytometry, ELISA, Immunohistochemistry | |
4D12 | |
Western Blot 1:500-1:5000, Flow Cytometry 1:20-1:200, ELISA, Immunohistochemistry 1:50-1:200 | |
Acylation Stimulating Protein, acylation-stimulating protein cleavage product, AHUS5, ARMD9, ASP, C3, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, C3a, C3a anaphylatoxin, C3adesArg, C3b, C3bc, C3-beta-c, complement C3, Complement C3 alpha chain, Complement C3 beta chain, Complement C3b alpha' chain, Complement C3c alpha' chain fragment 1, Complement C3c alpha' chain fragment 2, Complement C3d fragment, Complement C3dg fragment, Complement C3f fragment, Complement C3g fragment, complement component 3, complement component C3, complement component C3a, complement component C3b, CPAMD1, EC 3.4.21.43, epididymis secretory sperm binding protein Li 62p, HEL-S-62p, prepro-C3 | |
A synthesized peptide derived from Human Complement C3 [UniProt P01024] | |
100 μL | |
Angiogenesis, Apoptosis, Autoimmune Diseases, Immunology, Inflammation, Innate Immunity, Mesenchymal Stem Cell Markers, Neurodegeneration, Neuroscience, Signal Transduction | |
718 | |
Store at -20 to -70C. Avoid freeze-thaw cycles. | |
IgG |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Complement C3 Antibody (4D12), Novus Biologicals™ > 100 μL; Unconjugated
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido